Featured Research

from universities, journals, and other organizations

Regular Salmeterol For Asthma: More Evidence Of Long-term Problems

Date:
July 15, 2008
Source:
Wiley-Blackwell
Summary:
People with asthma who regularly use salmeterol are at a greater risk of non-fatal serious adverse events than those using placebos. This conclusion was arrived at by a team of Cochrane researchers who drew together data from 26 trials involving 62,630 patients.

People with asthma who regularly use salmeterol are at a greater risk of non-fatal serious adverse events than those using placebos. This conclusion was arrived at by a team of Cochrane Researchers who drew together data from 26 trials involving 62,630 patients.

Related Articles


The researchers found that over a four to six month period, for every thousand people treated for asthma there were 45 who suffered a serious adverse event on regular salmeterol, compared to only 40 if a placebo inhaler was given.

Salmeterol is a long-acting beta2-agonist. It is inhaled by people with asthma twice daily, and relieves symptoms for up to 12 hours. It is generally recommended for use along with corticosteroid inhalers (also known as preventer inhalers).

Over the last decade some researchers and practitioners have expressed anxieties that although salmeterol can relieve asthma symptoms, it could cause long-term problems.

"We found that the biggest increase in risk was seen in people with asthma who were not taking inhaled corticosteroids; however, there is no guarantee that inhaled corticosteroids abolish the risk all together," says lead researcher Christopher Cates who works in Community Health Sciences at St George's, London, UK.

The authors recommend that people should follow the manufacturer's advice not to increase the dose of salmeterol during an exacerbation. Furthermore regular salmeterol should not be used as an alternative to inhaled corticosteroids. Benefits and risks both need to be considered before embarking on long term treatment with regular salmeterol.

Work is currently in progress on a similar assessment of formoterol (another long-acting beta2-agonist).


Story Source:

The above story is based on materials provided by Wiley-Blackwell. Note: Materials may be edited for content and length.


Cite This Page:

Wiley-Blackwell. "Regular Salmeterol For Asthma: More Evidence Of Long-term Problems." ScienceDaily. ScienceDaily, 15 July 2008. <www.sciencedaily.com/releases/2008/07/080715204837.htm>.
Wiley-Blackwell. (2008, July 15). Regular Salmeterol For Asthma: More Evidence Of Long-term Problems. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2008/07/080715204837.htm
Wiley-Blackwell. "Regular Salmeterol For Asthma: More Evidence Of Long-term Problems." ScienceDaily. www.sciencedaily.com/releases/2008/07/080715204837.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins